A recombinant zoster vaccine builds strong antibody protection in people living with HIV, regardless of their CD4 count — but their cellular immune response still lags behind those without HIV.
Health officials in the country raised the alarm over its rising HIV infection rates, which have surged 16-fold in seven ...
Young people living with HIV manage their condition better when their antiretroviral therapy is given by injections every eight weeks rather than daily tablets, according to results of a trial in ...
One in 60 adults in the tiny Pacific nation of less than a million people are living with the virus.
Your step-by-step guide to getting LEN — from the HIV test and four starter pills to two tummy jabs and your next appointment ...
Global efforts to prevent HIV lost ground last year as funding disruptions forced countries to scale back services, even as ...
Sept 15 (Reuters) - U.S. drugmaker Gilead Sciences said on Tuesday it had reached an agreement with the Pan American Health ...
Gilead Sciences (NASDAQ:GILD) executives outlined plans to expand the company’s HIV prevention and treatment franchises while ...